- Home
- ABUS vs CSV Comparison
ABUS vs CSV Comparison
Compare ABUS & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- CSV
- Stock Information
- Founded
- ABUS 2005
- CSV 1991
- Country
- ABUS United States
- CSV United States
- Employees
- ABUS N/A
- CSV N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- CSV Other Consumer Services
- Sector
- ABUS Health Care
- CSV Consumer Discretionary
- Exchange
- ABUS Nasdaq
- CSV Nasdaq
- Market Cap
- ABUS 711.2M
- CSV 725.2M
- IPO Year
- ABUS N/A
- CSV 1996
- Fundamental
- Price
- ABUS $4.20
- CSV $42.73
- Analyst Decision
- ABUS Strong Buy
- CSV Strong Buy
- Analyst Count
- ABUS 3
- CSV 3
- Target Price
- ABUS $5.67
- CSV $58.67
- AVG Volume (30 Days)
- ABUS 1.0M
- CSV 118.1K
- Earning Date
- ABUS 11-05-2025
- CSV 10-29-2025
- Dividend Yield
- ABUS N/A
- CSV 1.05%
- EPS Growth
- ABUS N/A
- CSV 75.49
- EPS
- ABUS N/A
- CSV 3.32
- Revenue
- ABUS $15,416,000.00
- CSV $407,603,000.00
- Revenue This Year
- ABUS $138.02
- CSV $3.82
- Revenue Next Year
- ABUS N/A
- CSV $2.27
- P/E Ratio
- ABUS N/A
- CSV $12.88
- Revenue Growth
- ABUS 53.23
- CSV 3.15
- 52 Week Low
- ABUS $2.71
- CSV $30.15
- 52 Week High
- ABUS $4.73
- CSV $49.41
- Technical
- Relative Strength Index (RSI)
- ABUS 84.85
- CSV 35.60
- Support Level
- ABUS $3.60
- CSV $42.19
- Resistance Level
- ABUS $4.10
- CSV $44.73
- Average True Range (ATR)
- ABUS 0.17
- CSV 0.95
- MACD
- ABUS 0.06
- CSV -0.31
- Stochastic Oscillator
- ABUS 83.33
- CSV 12.86
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About CSV Carriage Services Inc.
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.